Simultaneous development of pneumonitis and autoimmune diabetes secondary to immune checkpoint inhibitor treatment with durvalumab in an advanced small cell lung cancer patient: A case report

Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of various types of cancers worldwide, which is the most significant breakthrough in cancer therapy in recent years. Despite their excellent benefits in anti-tumor efficacy, a subset of patients will experience various autoim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Yan-Ping, Xiao, Hai-Wei, Yin, Ju-Hua, Guo, Hui-Ru, Shan, Meng-Jun, Shen, Li-Ping, Liu, Ling-Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726362/
https://www.ncbi.nlm.nih.gov/pubmed/36482651
http://dx.doi.org/10.1097/MD.0000000000032076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726362/
https://www.ncbi.nlm.nih.gov/pubmed/36482651
http://dx.doi.org/10.1097/MD.0000000000032076

Ejemplares similares